Current status of prophylactic antibiotic therapy for prevention of postoperative infections after gastrointestinal surgery A questionnaire covering 3, 823 surgeons

Objectives: Guidelines issued by the CDC or the “Guidelines for Antibiotic Usage”(issued by the Japanese Association for Infectious Diseases and the Japanese Society of Chemotherapy) give currently recommended prophylaxis with antibiotics. We surveyed the status of their implementation. Methods: In...

Full description

Saved in:
Bibliographic Details
Published inJapanese Journal of Chemotherapy Vol. 52; no. 9; pp. 474 - 485
Main Authors Takesue, Yoshio, Sumiyama, Yoshinobu
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 25.09.2004
公益社団法人 日本化学療法学会
Subjects
Online AccessGet full text
ISSN1340-7007
1884-5886
DOI10.11250/chemotherapy1995.52.474

Cover

Loading…
Abstract Objectives: Guidelines issued by the CDC or the “Guidelines for Antibiotic Usage”(issued by the Japanese Association for Infectious Diseases and the Japanese Society of Chemotherapy) give currently recommended prophylaxis with antibiotics. We surveyed the status of their implementation. Methods: In August and September 2003, a questionnaire was distributed to 3, 823 surgeons in 47 Japanese administrative districts (567 surgeons in Hokkaido/Tohoku, 1, 051 in Kanto, 324 in Tokai, 262 in Hokuriku/Shinetsu, 643 in Kinki, 495 in Chugoku/Shikoku, and 481 in Kyushu/Okinawa). The implementation of recommendations in guidelines was compared for geographic area, type of hospital, number of beds, and clinical experience of surgeons. Results: Implementation of recommendations was 35% in the selection of prophylactic antibiotics (large bowel, second-generation cephamycins) and 63% for the timing of administration (just prior to surgery). For the administration period (<=4 days), implementation was 63% for gastric surgery (56% for 3 to 4days and 7% for short-term therapy) and 51% for large bowel surgery. Implementation was low for the selection of prophylactic antibiotics. The highest implementation of long-term administration was 49% in the Tokai area. Concerning the type of hospital, a difference in long-term administration was seen between general hospitals (44%) and educational hospitals (31%). Concerning the number of beds, hospitals with fewer than 100 beds showed a lower rate of adherence to recommendations than hospitals having 500 or more beds, including lower administration just prior to surgery (45% vs. 66%) and higher long-term administration (62% vs. 34%). Concerning clinical experience, more surgeons with less than 5 years of experience followed recommendations than surgeons who had 20 years or more of experience, especially for selection of antibiotics (41% vs. 34%), timing of administration (73% vs. 55%), and administration period (68% vs. 59%). Conclusions: Implementation of recommendations was low and further education is thought to be necessary in general hospitals or hospitals with fewer than 100 beds and among surgeons with 20 years of experience or more. Concerning the administration period and the selection of antibiotics for large bowel surgery, marked differences were seen from CDC recommendations, so it may be desirable for randomized clinical trials to be conducted in Japan.
AbstractList Objectives: Guidelines issued by the CDC or the “Guidelines for Antibiotic Usage”(issued by the Japanese Association for Infectious Diseases and the Japanese Society of Chemotherapy) give currently recommended prophylaxis with antibiotics. We surveyed the status of their implementation.Methods: In August and September 2003, a questionnaire was distributed to 3, 823 surgeons in 47 Japanese administrative districts (567 surgeons in Hokkaido/Tohoku, 1, 051 in Kanto, 324 in Tokai, 262 in Hokuriku/Shinetsu, 643 in Kinki, 495 in Chugoku/Shikoku, and 481 in Kyushu/Okinawa). The implementation of recommendations in guidelines was compared for geographic area, type of hospital, number of beds, and clinical experience of surgeons.Results: Implementation of recommendations was 35% in the selection of prophylactic antibiotics (large bowel, second-generation cephamycins) and 63% for the timing of administration (just prior to surgery). For the administration period (<=4 days), implementation was 63% for gastric surgery (56% for 3 to 4days and 7% for short-term therapy) and 51% for large bowel surgery. Implementation was low for the selection of prophylactic antibiotics. The highest implementation of long-term administration was 49% in the Tokai area. Concerning the type of hospital, a difference in long-term administration was seen between general hospitals (44%) and educational hospitals (31%). Concerning the number of beds, hospitals with fewer than 100 beds showed a lower rate of adherence to recommendations than hospitals having 500 or more beds, including lower administration just prior to surgery (45% vs. 66%) and higher long-term administration (62% vs. 34%). Concerning clinical experience, more surgeons with less than 5 years of experience followed recommendations than surgeons who had 20 years or more of experience, especially for selection of antibiotics (41% vs. 34%), timing of administration (73% vs. 55%), and administration period (68% vs. 59%).Conclusions: Implementation of recommendations was low and further education is thought to be necessary in general hospitals or hospitals with fewer than 100 beds and among surgeons with 20 years of experience or more. Concerning the administration period and the selection of antibiotics for large bowel surgery, marked differences were seen from CDC recommendations, so it may be desirable for randomized clinical trials to be conducted in Japan. 【目的】現在推奨される予防抗菌薬使用法がCDCのガイドラインや「抗菌薬使用の手引き」で勧告されているが, その実施の現状を把握する。【方法】2002年8-9月に, 47都道府県3, 823名 (北海道・東北567名, 関東1, 051名, 東海324名, 北陸・信越262名, 近畿643名, 中国・四国495名, 九州・沖縄481名) の外科医に対しアンケート調査を実施し, 地区別, 病院機能別, ベッド数別, 臨床経験年数別に勧告に対する実施率を比較した。【結果】勧告の実施率は, 予防抗菌薬の選択 (下部消化管, 第置.世代セファマイシン) 35%, 投与時期 (術直前) 63%, 投与期間 (4日以内);胃手術63%(3, 4日56%+短期7%), 大腸手術51%であり, 特に予防抗菌薬選択での実施率が低率であった。地区別では東海が長期投与53%と最も高率であった。病院機能別では, 長期投与は一般病院44%, 教育病院31%と差を認めた。ベット数別では, 100床未満の病院は500床以上と比較し術直前投与実施率が低く (45%vs66%), 長期投与が高率 (62%, 31%) であり, 勧告が守られていなかった。臨床経験年数別では, 5年未満のほうが20年以上.より, 薬剤選択 (41%vs34%), 投与時期 (73%vs55%), 投与期間 (68%vs59%), いずれも推奨されている内容の回答が高率に得られた。【結論】勧告の実施率は未だ低率で, 一般病院, 100床未満, 臨床経験年数20年以上でのさらなる啓蒙が必要と考えた。投与期間, 下部消化管手術での抗菌薬の選択に関しては, CDCの勧告と大きく異なっており, 日本でのrandomized controlledtrial (RCT) の実施が望まれる。
Objectives: Guidelines issued by the CDC or the “Guidelines for Antibiotic Usage”(issued by the Japanese Association for Infectious Diseases and the Japanese Society of Chemotherapy) give currently recommended prophylaxis with antibiotics. We surveyed the status of their implementation. Methods: In August and September 2003, a questionnaire was distributed to 3, 823 surgeons in 47 Japanese administrative districts (567 surgeons in Hokkaido/Tohoku, 1, 051 in Kanto, 324 in Tokai, 262 in Hokuriku/Shinetsu, 643 in Kinki, 495 in Chugoku/Shikoku, and 481 in Kyushu/Okinawa). The implementation of recommendations in guidelines was compared for geographic area, type of hospital, number of beds, and clinical experience of surgeons. Results: Implementation of recommendations was 35% in the selection of prophylactic antibiotics (large bowel, second-generation cephamycins) and 63% for the timing of administration (just prior to surgery). For the administration period (<=4 days), implementation was 63% for gastric surgery (56% for 3 to 4days and 7% for short-term therapy) and 51% for large bowel surgery. Implementation was low for the selection of prophylactic antibiotics. The highest implementation of long-term administration was 49% in the Tokai area. Concerning the type of hospital, a difference in long-term administration was seen between general hospitals (44%) and educational hospitals (31%). Concerning the number of beds, hospitals with fewer than 100 beds showed a lower rate of adherence to recommendations than hospitals having 500 or more beds, including lower administration just prior to surgery (45% vs. 66%) and higher long-term administration (62% vs. 34%). Concerning clinical experience, more surgeons with less than 5 years of experience followed recommendations than surgeons who had 20 years or more of experience, especially for selection of antibiotics (41% vs. 34%), timing of administration (73% vs. 55%), and administration period (68% vs. 59%). Conclusions: Implementation of recommendations was low and further education is thought to be necessary in general hospitals or hospitals with fewer than 100 beds and among surgeons with 20 years of experience or more. Concerning the administration period and the selection of antibiotics for large bowel surgery, marked differences were seen from CDC recommendations, so it may be desirable for randomized clinical trials to be conducted in Japan.
Author Takesue, Yoshio
Sumiyama, Yoshinobu
Author_FL 炭山 嘉伸
竹末 芳生
Author_FL_xml – sequence: 1
  fullname: 炭山 嘉伸
– sequence: 2
  fullname: 竹末 芳生
Author_xml – sequence: 1
  fullname: Takesue, Yoshio
  organization: Department of Surgery Division of Clinical Medical Science Programs for Applied Biomedicine Graduate School of Biomedical Sciences Hiroshima University
– sequence: 1
  fullname: Sumiyama, Yoshinobu
  organization: 3rd Department of Surgery, Toho University School of Medicine
BackLink https://cir.nii.ac.jp/crid/1390001206286570112$$DView record in CiNii
BookMark eNpdkEtrQjEQhUNpodb6H7Lo9tok9-a1LNIXCN2060uME41ockmiIP3zjdVF6WZm4Jwzw3x36DrEAAhhSqaUMk4e7Rp2sawhmeFIteZTzqad7K7QiCrVNVwpcV3ntiONJETeoknOfkEIpUS0VI_Q92yfEoSCczFln3F0eEhxWB-3xhZvsQnFL3w8jZcz2MVUPXCoKR_DbyLmEoeqFn8A7IMDe5IyNq5AwiuTS4o-FMjFB7PFeZ9WkI736MaZbYbJpY_R18vz5-ytmX-8vs-e5s2GClEay1slpVGKQkc1Y5wTa1pNjOXOCNd1jguppdWWLSVxWgoGSyblctEuFKWiHaOH897gfW_9qdKarxQYEUwJLisPVm3zs21TWaygH5LfmXTsTarfb6H_z7rnrNfnUpH_sZnUQ2h_AOy_g3c
ContentType Journal Article
Copyright Japanese Society of Chemotherapy
Copyright_xml – notice: Japanese Society of Chemotherapy
DBID RYH
DOI 10.11250/chemotherapy1995.52.474
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate 消化器外科領域における術後感染予防抗菌薬使用の現状―外科医3,823名に対するアンケート調査
A questionnaire covering 3, 823 surgeons
外科医3,823名に対するアンケート調査
DocumentTitle_FL 消化器外科領域における術後感染予防抗菌薬使用の現状―外科医3,823名に対するアンケート調査
EISSN 1884-5886
EndPage 485
ExternalDocumentID 130004102706
article_chemotherapy1995_52_9_52_9_474_article_char_en
GroupedDBID 5GY
ALMA_UNASSIGNED_HOLDINGS
DIK
JSF
KQ8
P2P
RJT
RYH
ID FETCH-LOGICAL-j166t-c53877a881e41922550ca390ac5fa6f44f56797c9c2d70f9762ed277db3b81163
ISSN 1340-7007
IngestDate Thu Jun 26 23:05:55 EDT 2025
Wed Sep 03 06:25:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j166t-c53877a881e41922550ca390ac5fa6f44f56797c9c2d70f9762ed277db3b81163
OpenAccessLink https://www.jstage.jst.go.jp/article/chemotherapy1995/52/9/52_9_474/_article/-char/en
PageCount 12
ParticipantIDs nii_cinii_1390001206286570112
jstage_primary_article_chemotherapy1995_52_9_52_9_474_article_char_en
PublicationCentury 2000
PublicationDate 2004/09/25
PublicationDateYYYYMMDD 2004-09-25
PublicationDate_xml – month: 09
  year: 2004
  text: 2004/09/25
  day: 25
PublicationDecade 2000
PublicationTitle Japanese Journal of Chemotherapy
PublicationTitleAlternate Jpn. J. Chemother.
PublicationTitle_FL Jpn. J. Chemother
日化療会誌
日本化学療法学会雑誌
PublicationYear 2004
Publisher Japanese Society of Chemotherapy
公益社団法人 日本化学療法学会
Publisher_xml – name: Japanese Society of Chemotherapy
– name: 公益社団法人 日本化学療法学会
References 8) Classen D C, Evance R S, Pestonik S L, et al: The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 326: 281-286, 1992
12) Takesue Y, Yokoyama T, Murakami Y, et al: Prediction for the development of postoperative infections in the operation of esophageal cancer compared with gastric surgery. Hiroshima J Med Sci 47: 109-113, 1998
6) Song F, Glenny A M: Antimicrobial prophylaxis in colorectal surgery: a systemic review of randomized controlled trial. Brit J Surg 85: 1232-1241, 1998
10) Harbarth S, Samore M H, Lichtenberg D, et al: Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 101: 2916-2921, 2000
4) Antonelli W, Borgani A, Machella C, et al: Comparison of two systemic antibiotics for the prevention of complications in elective colorectal surgery. Italian J Surg Sciences 15: 255-258, 1985
1) Mangram A J, Horan T C, Pearson M L, et al: Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 20: 247-278, 1999
5) Jones R N, Wojeski W, Bakke J, et al: Antibiotic prophylaxis of 1036 patients undergoing elective surgical procedures. A prospective randomized comparative trial of cefazoline, cefoxitin and cefotaxime in a prepaid medical practice. Am J Surg 153: 341-346, 1987
2) 炭山嘉伸: 一般消化器外科領域. 抗菌薬使川の子引き (日本感染症学会, 日本化学療法学会編), p.107-113, 協和企画, 東京, 2001
7) Burk J F: The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50: 161-168, 1961
9) Takesue Y, Yokoyama T, Akagi S, et al: Changes in the intestinal flora after the administration of prophylactic antibiotics to patients undergoing a gastrectomy. Surg Today 32: 581-586, 2002
3) Keighley M R B, Williams N S: Sepsis and the use of antibiotic cover in colorectal surgery. In Surgery of the anus, rectum and colon, 2nd ed (Keighley M R B, Williams N S eds), p.107-135, WB Saunders, London, 1999
11) Dipiro J T, Cheung R P F, Boweden T A, et al: Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 152: 552-559, 1986
References_xml – reference: 2) 炭山嘉伸: 一般消化器外科領域. 抗菌薬使川の子引き (日本感染症学会, 日本化学療法学会編), p.107-113, 協和企画, 東京, 2001
– reference: 4) Antonelli W, Borgani A, Machella C, et al: Comparison of two systemic antibiotics for the prevention of complications in elective colorectal surgery. Italian J Surg Sciences 15: 255-258, 1985
– reference: 7) Burk J F: The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50: 161-168, 1961
– reference: 1) Mangram A J, Horan T C, Pearson M L, et al: Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 20: 247-278, 1999
– reference: 9) Takesue Y, Yokoyama T, Akagi S, et al: Changes in the intestinal flora after the administration of prophylactic antibiotics to patients undergoing a gastrectomy. Surg Today 32: 581-586, 2002
– reference: 10) Harbarth S, Samore M H, Lichtenberg D, et al: Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 101: 2916-2921, 2000
– reference: 6) Song F, Glenny A M: Antimicrobial prophylaxis in colorectal surgery: a systemic review of randomized controlled trial. Brit J Surg 85: 1232-1241, 1998
– reference: 12) Takesue Y, Yokoyama T, Murakami Y, et al: Prediction for the development of postoperative infections in the operation of esophageal cancer compared with gastric surgery. Hiroshima J Med Sci 47: 109-113, 1998
– reference: 8) Classen D C, Evance R S, Pestonik S L, et al: The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 326: 281-286, 1992
– reference: 5) Jones R N, Wojeski W, Bakke J, et al: Antibiotic prophylaxis of 1036 patients undergoing elective surgical procedures. A prospective randomized comparative trial of cefazoline, cefoxitin and cefotaxime in a prepaid medical practice. Am J Surg 153: 341-346, 1987
– reference: 11) Dipiro J T, Cheung R P F, Boweden T A, et al: Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 152: 552-559, 1986
– reference: 3) Keighley M R B, Williams N S: Sepsis and the use of antibiotic cover in colorectal surgery. In Surgery of the anus, rectum and colon, 2nd ed (Keighley M R B, Williams N S eds), p.107-135, WB Saunders, London, 1999
SSID ssib001106319
ssib050995465
ssib000940262
ssib001168255
ssib038076210
ssib002822060
ssib002670600
ssib058493824
ssj0003212010
Score 1.6689975
Snippet Objectives: Guidelines issued by the CDC or the “Guidelines for Antibiotic Usage”(issued by the Japanese Association for Infectious Diseases and the Japanese...
SourceID nii
jstage
SourceType Publisher
StartPage 474
SubjectTerms cephamycin
colorectal surgery
postoperative infection
prophylactic antimicrobial agent
questionnaire
survey
Subtitle A questionnaire covering 3, 823 surgeons
Title Current status of prophylactic antibiotic therapy for prevention of postoperative infections after gastrointestinal surgery
URI https://www.jstage.jst.go.jp/article/chemotherapy1995/52/9/52_9_474/_article/-char/en
https://cir.nii.ac.jp/crid/1390001206286570112
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Japanese Journal of Chemotherapy, 2004/09/25, Vol.52(9), pp.474-485
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9MwFLa6ceGCQIAYMOQDtyklcRzHOSIYGkNw6qTdIsdJIIUlVZsegP-Ov4zPsdN4P5Bg4mKlbhJX7321PyfvfY-Qlyyro7BkcaAlUwFPyzKQRcgDLmStVQREM5Pg_PGTODnjp-fJ-Wz2y4ta2vbFXP-4Ma_kNl5FH_xqsmT_wbO7m6IDx_AvWngY7V_5eBRXMllB2yEmA_Mh7PZtyHw6gtGaounMoU2zssGZK6faZJniyihrrConAD7GZrUbVz38s9r0686ISmAuMMx1cz2P-hQLrilkeeSxWyNE4JK7dg_tF-prBS8Ps363-WIjwOwbqYvmu7pQu2_artheeh7BTfCEzV22a8U45Bh1etOQdq6NTTBjaIvezivbJyUPEunUsd0EnTAPiJk323Jb4Mct3NzW_rm-JoDlwZPa-xEmL32esPnuBpcUt50_86tX5AnLM9vgwnw6Ta2Bxj1yh2GrYhaHt-8_eBQWO3RPkhF0S8S-hF4ksEn3KKswekYeJQODC6ctrKkPINhE2cD3MlPPfvdZ8iyWLuPHsJEY3CS0ohyjvceANtjl1R-sAj62BHaN7MRe2zQe5VrcJ_ccmuhra4EHZLZUD8lPB3pqQU-7mvqgpxPoqRuQAvR0Av1whQ96OoGeDqCnV0FPHegfkbN3x4s3J4GrIBIsIyH6QGM5T1MlZVSZaAfYOdQqzkKlk1qJmvM6EWmW6kyzMg1rUHNWlfBiWcSFhGfix2S_7drqCaFalioqRGHEozhIvyy1UDivAiMWoZIH5NhaLF9ZmZj8djA6IIcweK4b02J7NjwqDocE8hRgYU__0zjPyN3p3_uc7PfrbXUIft0XLwYA_wYbPNM2
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+status+of+prophylactic+antibiotic+therapy+for+prevention+of+postoperative+infections+after+gastrointestinal+surgery&rft.jtitle=Japanese+Journal+of+Chemotherapy&rft.au=Takesue%2C+Yoshio&rft.au=Sumiyama%2C+Yoshinobu&rft.date=2004-09-25&rft.pub=Japanese+Society+of+Chemotherapy&rft.issn=1340-7007&rft.eissn=1884-5886&rft.volume=52&rft.issue=9&rft.spage=474&rft.epage=485&rft_id=info:doi/10.11250%2Fchemotherapy1995.52.474&rft.externalDocID=article_chemotherapy1995_52_9_52_9_474_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1340-7007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1340-7007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1340-7007&client=summon